ISIS PHARMACEUTICALS INC 4
4 · ISIS PHARMACEUTICALS INC · Filed May 11, 2007
Insider Transaction Report
Form 4
Wedel Mark K
VP & Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2007-05-09$5.15/sh+2,800$14,420→ 9,403 total - Sale
Common Stock
2007-05-09$10.36/sh−2,800$29,019→ 6,603 total - Exercise/Conversion
Employee Stock Purchase (right to buy)
2007-05-09−2,800→ 5,700 totalExercise: $5.15From: 2006-01-01Exp: 2008-12-31→ Common Stock (2,800 underlying)
Footnotes (2)
- [F1]The purchase reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/28/07.
- [F2]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/28/07.